Okamura K, Ueda K, Sone H, Ikenoue H, Hasuo Y, Sato K, Yoshinari M, Fujishima M
Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Am Geriatr Soc. 1989 Apr;37(4):317-22. doi: 10.1111/j.1532-5415.1989.tb05497.x.
The use of a screening test for thyroid functional disorder by sensitive thyroid stimulating hormone assay in the elderly was investigated. The basal thyroid stimulating hormone levels predicted the response of thyroid stimulating hormone to thyrotropin releasing hormone; it was suppressed in 99 (99.0%) of 100 hyperthyroid patients. Therefore, not only primary hypothyroidism but also hyperthyroidism can be excluded when the serum thyroid stimulating hormone levels are normal. An epidemiological study was then performed on 2,421 (76.7%) of the Japanese general population aged 40 or over recruited from the residents in Hisayama town and also in 122 residents between 20 and 40 years of age. Additional free T4 measurement was necessary in about 10% of the residents with abnormal TSH levels to confirm the diagnosis of hyperthyroidism or distinguish latent from overt hypothyroidism. There was a significant correlation between age and serum thyroid stimulating hormone levels after logarithmic conversion (r = 0.1533, P less than .001). The prevalence of thyroid dysfunction found in 1,026 males and in 1,395 females aged 40 or over was, respectively: hyperthyroidism, less than 0.1% and 0.2%, latent (subclinical) hypothyroidism, 3.2% and 5.5%, and overt hypothyroidism, 0.4% and 0.7%. We conclude that the screening with this sensitive thyroid stimulating hormone assay and additional free T4 measurement is useful for detection of patients with thyroid functional disorder.
我们对在老年人中使用敏感促甲状腺激素检测法筛查甲状腺功能障碍进行了研究。基础促甲状腺激素水平可预测促甲状腺激素对促甲状腺激素释放激素的反应;100例甲状腺功能亢进患者中有99例(99.0%)该反应被抑制。因此,当血清促甲状腺激素水平正常时,不仅可以排除原发性甲状腺功能减退,还可以排除甲状腺功能亢进。随后,我们对从久山町居民中招募的2421名40岁及以上的日本普通人群(占76.7%)以及122名20至40岁的居民进行了一项流行病学研究。约10%促甲状腺激素水平异常的居民需要额外检测游离T4,以确诊甲状腺功能亢进或区分潜伏性与显性甲状腺功能减退。对数转换后,年龄与血清促甲状腺激素水平之间存在显著相关性(r = 0.1533,P <.001)。在1026名40岁及以上男性和1395名40岁及以上女性中发现的甲状腺功能障碍患病率分别为:甲状腺功能亢进,低于0.1%和0.2%;潜伏性(亚临床)甲状腺功能减退,3.2%和5.5%;显性甲状腺功能减退,0.4%和0.7%。我们得出结论,采用这种敏感促甲状腺激素检测法并额外检测游离T4进行筛查,有助于检测出甲状腺功能障碍患者。